DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for RVFV nucleocapsid (N) protein RNA-binding activity are 5

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_5212	Suramin Sodium	Antiparasitic products, Insectisides and Repellents	Sleeping sickness | Onchocerciasis	Rift Valley fever virus	NA	NA	RVFV nucleocapsid (N) protein RNA-binding activity	Decrease (50 %)	Investigational	22644268
DrugRepV_5213	Quinacrine Dihydrochloride	NA	Malaria | Giardiasis | Cutaneous leishmaniasis | Management of malignant effusions	Rift Valley fever virus	NA	NA	RVFV nucleocapsid (N) protein RNA-binding activity	Decrease (50 %)	Investigational	22644268
DrugRepV_5214	N-methyl-2,3-diphenyl-1,2,4-thiadiazol-5-imine;hydrobromide	NA	NA	Rift Valley fever virus	NA	NA	RVFV nucleocapsid (N) protein RNA-binding activity	Decrease (50 %)	NA	22644268
DrugRepV_5215	4-(3,6-dioxocyclohexa-1,4-dien-1-yl)benzoic acid	NA	NA	Rift Valley fever virus	NA	NA	RVFV nucleocapsid (N) protein RNA-binding activity	Decrease (50 %)	NA	22644268
DrugRepV_5216	BTB 11461	NA	NA	Rift Valley fever virus	NA	NA	RVFV nucleocapsid (N) protein RNA-binding activity	Decrease (50 %)	NA	22644268